×

Alnylam off as development of key drug discontinued

5:11 PM ET Wed, 5 Oct 2016

Shares of Alnylam are tanking after-hours following the discontinuation of development of the company's second most advanced drug. CNBC's Meg Tirrell reports.The "Fast Money" traders weigh in.